Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of adding the investigational drug
Motexafin Gadolinium to the standard treatment of radiation therapy and chemotherapy with
drugs called 5-FU and cisplatin in patients with advanced head and neck cancer.